Company / Depreciation & Amortization
Adaptive Biotechnologies Corp Depreciation & Amortization History
FY2017-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Depreciation & Amortization
$16.0M
FY2025
5-year range
$16.0M / $20.9M
FY2021-FY2025
Trend
-8.3%
vs FY2024
Sector context
#51 of 163
Health Care
What the data says
At $16M, Adaptive Biotechnologies Corp's depreciation & amortization ranks #113 of 163 in the Health Care sector. Depreciation & Amortization has declined for 3 consecutive years, from $21M in FY2022 to $16M in FY2025.
Based on SEC 10-K filings.
$16M in FY2025 with a 3-year CAGR of -8.5%.
Improved from $20M to $16M over the past 2 years.
Health Care sector context is included.
Depreciation & Amortization over time
Growth rates
- 3-Year CAGR
- -8.5%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#113 of 163 in Health CareTop 69% of 163This company $16.0M Sector average $219.4M
▼
-92.7% below sector average
Key checks
Key Insights
- Adaptive Biotechnologies Corp's depreciation & amortization has declined for 3 consecutive years.
- 3-year CAGR of -8.5%, indicating a declining trend.
- In FY2025, depreciation & amortization decreased 8.3% year-over-year.
- Ranks #51 out of 163 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score -1.45 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Depreciation & AmortizationValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $16.0M | -8.3% |
| FY2024 | $17.4M | -11.0% |
| FY2023 | $19.6M | -6.3% |
| FY2022 | $20.9M | - |
| FY2021 | - | - |
| FY2020 | - | - |
| FY2019 | - | - |
| FY2018 | $4.3M | +4.9% |
| FY2017 | $4.1M | - |
As of FY2025 · SEC 10-K · Updated Jul 1, 2026